ArticleCells2020

Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer.

Estefanía Paula Juliá et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.